Selective and potent morpholinone inhibitors of the MDM2-p53 interaction

被引：0

作者：

Gonzalez, Ana Z. ^{[1
]}

Eksterowics, John ^{[1
]}

Beck, Hilary P. ^{[1
]}

Canon, Jude ^{[4
]}

Chen, Ada ^{[1
]}

Chow, David ^{[1
]}

Duquette, Jason ^{[1
]}

Fox, Brian M. ^{[1
]}

Fu, Jiasheng ^{[1
]}

Houze, Jonathan ^{[1
]}

Jin, Lixia ^{[1
]}

Li, Yihong ^{[1
]}

Li, Zhihong ^{[1
]}

Lo, Mei-Chu ^{[1
]}

Long, Alexander M. ^{[5
]}

McGee, Lawrence R. ^{[1
]}

McIntosh, Joel ^{[1
]}

Oliner, Jonathan D. ^{[4
]}

Osgood, Tao ^{[4
]}

Rew, Yosup ^{[1
]}

Saiki, Anne Y. ^{[4
]}

Shaffer, Paul ^{[5
]}

Wortman, Sarah ^{[2
]}

Yakowek, Peter ^{[5
]}

Yan, Xuelei ^{[1
]}

Ye, Qiuping ^{[3
]}

Yu, Dongyin ^{[4
]}

Zhao, Xiaoning ^{[1
]}

Zhou, Jing ^{[1
]}

Olson, Steven H. ^{[1
]}

Medina, Julio C. ^{[1
]}

Sun, Daqing ^{[1
]}

机构：

[1] Amgen Inc, Dept Therapeut Discovery, San Francisco, CA 94080 USA

[2] Amgen Inc, Pharmaceut, San Francisco, CA 94080 USA

[3] Amgen Inc, Dept Therapeut Discovery, Thousand Oaks, CA 91320 USA

[4] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, Dept Therapeut Discovery, Cambridge, MA 02142 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：1

共 50 条

[21] Novel inhibitors of the MDM2-p53 interaction featuring carboxylic acid isosteres
Gonzalez, Ana Z.
Li, Zhihong
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Duquette, Jason
Eksterowicz, John
Fox, Brian M.
Fu, Jiasheng
Huang, Xin
Houze, Jonathan
Jin, Lixia
Li, Yihong
Ling, Yun
Lo, Mei-Chu
Long, Alexander M.
Mcgee, Lawrence R.
McIntosh, Joel
Oliner, Jonathan D.
Osgood, Tao
Rew, Yosup
Saiki, Anne Y.
Shaffer, Paul
Wortman, Sarah
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Olson, Steven H.
Sun, Daqing
Medina, Julio C.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[22] Structure-Based Design of Novel Inhibitors of the MDM2-p53 Interaction
Rew, Yosup
Sun, Daqing
De Turiso, Felix Gonzalez-Lopez
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Deignan, Jeffrey
Fox, Brian M.
Gustin, Darin
Huang, Xin
Jiang, Min
Jiao, Xianyun
Jin, Lixia
Kayser, Frank
Kopecky, David J.
Li, Yihong
Lo, Mei-Chu
Long, Alexander M.
Michelsen, Klaus
Oliner, Jonathan D.
Osgood, Tao
Ragains, Mark
Saiki, Anne Y.
Schneider, Steve
Toteva, Maria
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Medina, Julio C.
Olson, Steven H.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 4936 - 4954
[23] Targeting the MDM2-p53 interaction for cancer therapy
Shangary, Sanjeev
Wang, Shaomeng
CLINICAL CANCER RESEARCH, 2008, 14 (17) : 5318 - 5324
[24] Total Mutagenesis and the Effects on the MDM2-p53 Interaction
Beyer, George
Thayer, Kelly
FASEB JOURNAL, 2015, 29
[25] Discovery of AM-7209, a Potent and Selective 4-Amidobenzoic Acid Inhibitor of the MDM2-p53 Interaction
Rew, Yosup
Sun, Daqing
Yan, Xuelei
Beck, Hilary P.
Canon, Jude
Chen, Ada
Duquette, Jason
Eksterowicz, John
Fox, Brian M.
Fu, Jiasheng
Gonzalez, Ana Z.
Houze, Jonathan
Huang, Xin
Jiang, Min
Jin, Lixia
Li, Yihong
Li, Zhihong
Ling, Yun
Lo, Mei-Chu
Long, Alexander M.
McGee, Lawrence R.
McIntosh, Joel
Oliner, Jonathan D.
Osgood, Tao
Saiki, Anne Y.
Shaffer, Paul
Wang, Yu Chung
Wortman, Sarah
Yakowec, Peter
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Medina, Julio C.
Olson, Steven H.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (24) : 10499 - 10511
[26] Therapeutic potential of a potent and selective antagonist of the MDM2-p53 interaction (MI-219) in combination with traditional chemotherapy
Shangary, S.
McEachern, D.
Liu, M.
Miller, R.
Qiu, S.
Nikolovska-Coleska, Z.
Wang, S.
EJC SUPPLEMENTS, 2008, 6 (12): : 137 - 137
[27] Human Dedifferentiated Liposarcomas Growth Inhibition by SAR299155, a Potent and Selective Disruptor of the MDM2-p53 Interaction
Dos-Santos, O.
Lagarde, P.
Perot, G.
Chibon, F.
Ratet, N.
Flamand, O.
Debussche, L.
EUROPEAN JOURNAL OF CANCER, 2012, 48 : S245 - S246
[28] An update patent review of MDM2-p53 interaction inhibitors (2019-2023)
Twarda-Clapa, Aleksandra
EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (12) : 1177 - 1198
[29] Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2-p53 interaction
Barakat, Assem
Islam, Mohammad Shahidul
Ghawas, Hussien Mansur
Al-Majid, Abdullah Mohammed
El-Senduny, Fardous F.
Badria, Farid A.
Elshaier, Yaseen A. M. M.
Ghabbour, Hazem A.
BIOORGANIC CHEMISTRY, 2019, 86 : 598 - 608
[30] Identification of equal affinity MDMX/MDM2-p53 interaction small molecule inhibitors
Reed, Damon
Mills, Nicholas
Guy, R. Kip
Dyer, Michael
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3404S - 3404S

← 1 2 3 4 5 →